BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Jeff Collins will serve as a judge in the Commercializing Innovation competition at the Wake Forest Business School in Winston-Salem, NC
News | 04. 24. 2008
